www.fdanews.com/articles/186010-oregon-governor-signs-price-transparency-bill-into-law
![signature.gif](https://www.fdanews.com/ext/resources/test/Device_Images2/signature.gif?t=1596243440&width=430)
Oregon Governor Signs Price Transparency Bill Into Law
March 15, 2018
Oregon Gov. Kate Brown signed a new bill into law requiring drugmakers to provide data justifying price hikes.
Under the new law, all drugmakers that raise the price of drugs more than 10 percent must report profits and the cost of R&D and marketing for them. They are also required to report the availability of generics. The first reports are due next July.
The law also creates a requirement that the state’s Department of Consumer and Business Services publish a list of drugs with high price increases.